Are there regulatory actions, recalls, or third-party lab tests for Dr. Oz branded weight loss supplements?

1. Legal fallout: class actions, settlements and pulled episodes

Multiple civil lawsuits allege that products touted on Dr. Oz’s show were promoted with misleading claims, producing monetary settlements and programmatic remedies: Mehmet Oz agreed to a roughly $5.25 million settlement in a false‑advertising class action over supplements he promoted (Woodard v. Labrada and related actions) and defendants agreed to measures including avoidance of re‑airing certain episodes that promoted those Labrada products ^{[1] [5] [2]}. Separate reporting and legal notices identify plaintiffs’ claims that products such as Labrada Garcinia Cambogia and Labrada Green Coffee Bean Extract were marketed as “magic” weight‑loss cures on his program while lacking scientific support ^{[1] [6]}.

2. Third‑party testing and undercover reporting: ConsumerLab and others

Independent testing and undercover reporting surfaced problems with supplements highlighted on Oz’s platforms: Dr. Oz’s team reportedly worked with ConsumerLab and found that samples from a private‑label supplier failed to contain the labeled amounts of active ingredients, and his show cited independent lab tests (for example EMSL in the apple‑juice episode) to support claims about contamination or mislabeling in some products he investigated ^{[3] [7]}. Industry and consumer‑testing accounts documented that several weight‑loss and slimming coffee products Oz purchased were previously identified by the FDA as adulterated, which his reporting acknowledged ^[4].

3. Regulatory warnings vs. formal recalls: what the sources show

The available reporting documents FDA warnings about certain weight‑loss products that Oz purchased or discussed (for example Fruta Planta and Health Slimming Coffee were the subject of FDA notices), but the sources provided do not show a named, formal FDA recall directly of a product labeled as “Dr. Oz” brand in these items; instead, they show regulatory attention to adulterated or mislabeled supplements in the wider weight‑loss category that Oz had spotlighted ^[4]. The distinction matters: regulatory warnings and agency focus on adulterated product categories are different from a formal recall action against a specific item marketed as Dr. Oz’s product line, and the supplied material does not supply evidence of that latter step ^[4].

4. Ongoing litigation and manufacturer exposure

While Oz settled or resolved media‑side claims, litigation continued or targeted manufacturers—reports note that litigation against supplement manufacturers persisted even as media defendants reached settlement agreements, with class definitions and eligibility tied to purchases of specific Labrada products during set timeframes ^{[1] [8] [2]}. Source summaries indicate plaintiffs alleged fraud, misrepresentation and unfair trade practices by manufacturers and promoters alike, underscoring that legal accountability has concentrated both on on‑air promotion and on manufacturing/labeling practices ^{[8] [1]}.

5. Limitations in the public record and alternative interpretations

The supplied reporting presents strong evidence of problematic products being highlighted and of independent lab failures and regulatory warnings, but it does not document a comprehensive government recall program explicitly targeting a “Dr. Oz” line of branded weight‑loss supplements; therefore, a cautious interpretation is that regulatory and legal actions have been significant and relevant—class actions, settlements, consumer‑lab failures and FDA warnings about products Oz showcased—but the sources do not prove there was an FDA recall of a supplement marketed under Dr. Oz’s personal brand name ^{[1] [2] [3] [4]}. Other outlets and regulatory databases would need to be searched to confirm any recall or FDA enforcement actions not captured in these items.